| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |